Publication | Closed Access
Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects
36
Citations
0
References
1984
Year
Maximal Fibrinolysis InhibitionWhole BloodPharmacotherapyPharmacokineticsRenal FunctionPharmacological StudyBioanalysisClinical ChemistryChronic Kidney DiseaseChromatographyNormal SubjectsBiochemistryFibrinolysisPharmacologyAntifibrinolytic EffectsPhysiologyEpsilon-aminocaproic Acid DistributionMetabolismMedicineRenal Eaca ClearanceNephrologyDrug Analysis
The kinetics of epsilon-aminocaproic acid (EACA) distribution and elimination were studied in six normal subjects after a single 10-gm iv dose. Steady-state distribution volume averaged 30.01 or 0.39 l/kg. Mean elimination t 1/2 was 294 min and the elimination clearance was 0.19 l/min. Renal excretion of unchanged EACA accounted for 68% of its elimination and renal EACA clearance averaged 115% of creatinine clearance. EACA antifibrinolytic effect kinetics were also characterized in five of the subjects by the monitoring of clot lysis times in whole blood and platelet-rich plasma. Peak antifibrinolytic effects were observed 15 to 60 min after peak EACA plasma concentrations were attained. A model of maximal fibrinolysis inhibition (Emax) was used to estimate a half-maximal inhibition (IC50) of 63 +/- 19.7 microgram/ml. This agrees with the value of 0.55 mM or 72 microgram/ml that has been reported for the dissociation constant of the EACA-plasminogen complex and is consistent with the proposed biochemical mechanism of EACA action.